Cargando…
Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes
BACKGROUND: A new special reimbursement scheme (SRS) for non-insulin medications used for treatment of hyperglycaemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The new SRS affected all community-dwelling Finnish T2D patients as all community-dwelling residents are eligi...
Autores principales: | Lavikainen, Piia, Aarnio, Emma, Jalkanen, Kari, Tirkkonen, Hilkka, Rautiainen, Päivi, Laatikainen, Tiina, Martikainen, Janne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694920/ https://www.ncbi.nlm.nih.gov/pubmed/33246453 http://dx.doi.org/10.1186/s12913-020-05952-6 |
Ejemplares similares
-
Data-driven long-term glycaemic control trajectories and their associated health and economic outcomes in Finnish patients with incident type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2022) -
Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis
por: Jalkanen, Kari, et al.
Publicado: (2021) -
LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model
por: Inglin, Laura, et al.
Publicado: (2021) -
Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population
por: Jalkanen, Kari, et al.
Publicado: (2019) -
Marked Improvement in A1C Levels After Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Maintained Over 4 Years in Patients With Type 1 Diabetes
por: Mustonen, Jyrki, et al.
Publicado: (2022)